ASX - Delayed Quote AUD
Vita Life Sciences Limited (VLS.AX)
1.7500
-0.0650
(-3.58%)
As of 11:41:29 AM GMT+10. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
79,505
79,505
74,161
66,886
57,101
Cost of Revenue
32,264
32,264
31,045
27,146
22,293
Gross Profit
47,241
47,241
43,116
39,740
34,808
Operating Expense
35,585
35,585
31,240
29,021
23,801
Operating Income
11,656
11,656
11,876
10,719
11,007
Net Non Operating Interest Income Expense
830
830
423
97
37
Other Income Expense
155
155
152
-78
157
Pretax Income
12,641
12,641
12,451
10,738
11,201
Tax Provision
3,862
3,862
3,373
3,397
2,954
Net Income Common Stockholders
8,784
8,784
9,080
7,084
8,292
Basic EPS
0.16
0.16
0.17
0.13
0.16
Diluted EPS
0.16
0.16
0.17
0.13
0.16
Basic Average Shares
55,619.7630
55,619.7630
53,666.9790
52,967.4320
52,635.9450
Diluted Average Shares
55,619.7630
55,619.7630
54,698.7950
53,993.9020
53,119.7950
Net Income from Continuing & Discontinued Operation
8,784
8,784
9,080
7,084
8,292
Normalized Income
8,784
8,784
9,080
7,084
8,292.7363
Interest Income
1,039
1,039
558
131
141
Interest Expense
209
209
135
34
104
Net Interest Income
830
830
423
97
37
EBIT
12,850
12,850
12,586
10,772
11,305
EBITDA
13,462
13,462
13,098
11,371
11,714
Reconciled Cost of Revenue
32,264
32,264
31,045
27,146
22,293
Reconciled Depreciation
612
612
512
599
409
Net Income from Continuing Operation Net Minority Interest
8,784
8,784
9,080
7,084
8,292
Total Unusual Items Excluding Goodwill
--
--
--
--
-1
Total Unusual Items
--
--
--
--
-1
Normalized EBITDA
13,462
13,462
13,098
11,371
11,715
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
--
-0.2637
12/31/2021 - 7/8/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade